Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Stopped The study was terminated due to enrollment challenges and the COVID-19 pandemic.

Conditions

• Rett Syndrome
• RTT

Interventions

• DRUG: GWP42003-P
• DRUG: Placebo

Sponsor

Jazz Pharmaceuticals